A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Clinical trial NCT02905578 · COMPLETED

Trial details

NCT number: NCT02905578
Sponsor: University of Iowa
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms Cancer of Pancreas Cancer of the Pancreas Neoplasms, Pancreatic Pancreas Cancer Pancreas Neoplasms Adenocarcinoma

Start date: 2018-11-28
Primary completion: 2024-08-26
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.